Financials
- Market Capitalization 150.973 M
- Employee 184
- Founded 2004
- CEO Laura Niklason
- Website www.humacyte.com
- Headquarter Delaware, United States
- FIGI BBG00XPPT7S7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.15
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 7181 | SRZNW Surrozen, Inc. - Warrant | 0.0066 USD | -48.44% | -31.25% | -34.65% | -63.13% | 253.80 M USD | ||
| 7270 | YDESW YD Bio Limited - Warrants | 0.2601 USD | +0.04% | +18.01% | +3.96% | -52.71% | 160.69 M USD | ||
| 7285 | FBIOP Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | 18.81 USD | +0.32% | -0.95% | -7.11% | +149.14% | 135.59 M USD | ||
| 7288 | ENGNW enGene Therapeutics Inc. - Warrants | 0.3079 USD | 0.00% | -3.78% | +20.27% | -64.61% | 126.61 M USD |